Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin

Journal of Investigative Dermatology

Volumn 124, Issue 5, 2005, Pages 971-975

  Dokka, Sujatha ^a   Cooper, Scott R ^a   Kelly, Susan ^a   Hardee, Gregory E ^a   Karras, James G ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

Hair follicle; Oligonucleotide; Topical delivery

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ISIS 13920; ISIS 18073;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG ACCUMULATION; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TRANSPORT; EPIDERMIS; FLUORESCENCE MICROSCOPY; HAIR FOLLICLE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; STRATUM CORNEUM;

EID: 18244379292     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23672.x     Document Type: Article

References (23)

1. Banga AK, Prausnitz MR: Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Trends Biotechnol 16:408-412, 1998
2. Brand RM, Iversen PL: Transdermal delivery of antisense compounds. Adv Drug Deliv Rev 44:51-57, 2000
3. Butler M, Stecker K, Bennett CF: Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab Invest 77:379-388, 1997
4. Cotsarelis G: The hair follicle as a target for gene therapy. Ann Dermatol Venereol 129:841-844, 2002
5. Elias PM, Cooper ER, Korc A, Brown BE: Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol 76:297-301, 1981
6. Lauer AC, Elder JT, Weiner ND: Evaluation of the hairless rat as a model for in vivo percutaneous absorption. J Pharm Sci 86:13-18, 1997
7. Lauer AC, Lieb LM, Ramachandran C, Flynn GL, Weiner ND: Transfollicular drug delivery. Pharm Res 12:179-186, 1995
8. Li L, Hoffman RM: The feasibility of targeted selective gene therapy of the hair follicle. Nat Med 1:705-706, 1995a
9. Li L, Hoffman RM: Model of selective gene therapy of hair growth: Liposome targeting of the active Lac-Z gene to hair follicles of histocultured skin. In Vitro Cell Dev Biol Anim 31:11-13, 1995b
10. Li L, Lishko V, Hoffman RM: Liposome targeting of high molecular weight DNA to the hair follicles of histocultured skin: A model for gene therapy of the hair growth processes. In Vitro Cell Dev Biol Anim 29A:258-260, 1993a
11. Li L, Lishko VK, Hoffman RM: Liposomes can specifically target entrapped melanin to hair follicles in histocultured skin. In Vitro Cell Dev Biol 29A:192-194, 1993b
12. Li L, Margolis LB, Lishko VK, Hoffman RM: Product-delivering liposomes specifically target hair follicles in histocultured intact skin. In Vitro Cell Dev Biol 28A:679-681, 1992
13. Lieb LM, Liimatta AP, Bryan RN, Brown BD, Krueger GG: Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro. J Pharm Sci 86:1022-1029, 1997
14. Mehta RC, Stecker KK, Cooper SR, et al: Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides. J Invest Dermatol 115:805-812, 2000
15. Mezei M, Gulasekharam V: Liposomes-a selective drug delivery system for the topical route of administration: Gel dosage form. J Pharm Pharmacol 34:473-474, 1982
16. Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, Freier SM: Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem 267:19954-19962, 1992
17. Monia BP, Lesnik EA, Gonzalez C, et al: Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268:14514-14522, 1993
18. Mrowietz U: The enigma of cyclosporin A treatment for psoriasis: Systemic efficacy versus topical non-responsiveness. A review. Acta Derm Venereol 72:321-326, 1992
19. Regnier V, Le Doan T, Preat V: Parameters controlling topical delivery of oligonucleotides by electroporation. J Drug Target 5:275-289, 1998
20. Schmook FP, Stutz A, Reinhardt J: Penetration of Sandimmune (cyclosporin A) in rat skin in vitro. Effects of penetration enhancers and solvents. Skin Pharmacol 6:116-124, 1993
21. Tezel A, Sens A, Tuchscherer J, Mitragotri S: Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J Pharm Sci 91:91-100, 2002
22. White PJ, Gray AC, Fogarty RD, Sinclair RD, Thumiger SP, Werther GA, Wraight CJ: C-S propyne-modified oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application. J Invest Dermatol 118:1003-1007, 2002
23. Zewert TE, Pliquett UF, Langer R, Weaver JC: Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem Biophys Res Commun 212:286-292, 1995